Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
B
Details...
Enter Symbol
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)
Sector: Medical
Current Price :
$128.05
52 Week Low
$44.96
52 Week High
$140.01
Company
Overview
Research Notes
Company Profile
Competitors
Community
Wiki
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Related News
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
93M
Market Cap:
$12.23B
Avg Volume:
884019
P/E Ratio:
-0.010
PEG Ratio:
3.360
Trade now with
1m
3m
6m
1y
2y
Opinion and Analysis
Goldman Sachs (GS): M&A Remains Dominant Theme In Healthcare This Year
May 11, 2012 10:01 AM |
AGN
,
ALXN
,
CERN
,
CPSI
,
CVH
,
EW
Insider Weekends – May 4, 2012
May 06, 2012 03:08 PM |
AAPL
,
AKAM
,
COO
,
HES
,
KO
,
LVLT
Watch This Stock: FDA Panel To Review On Regeneron’S Arcalyst On Tuesday
May 04, 2012 02:48 PM |
REGN
Regeneron (REGN) Price Target Raised To $140 From $80 By Deutsche Bank On Eylea Sales
Feb 15, 2012 01:58 PM |
REGN
Indices Close Ahead On Good Technicals
Feb 14, 2012 12:11 AM |
AAPL
,
APKT
,
CGI
,
DBD
,
DRYS
,
ETN
More Articles on REGN..
Market News
Scotts Miracle-Gro, Korn/Ferry are big movers
Jun 15, 2011 04:48 PM |
BBEP
,
BBY
,
JNJ
,
KFY
,
OI
,
REGN
Teen prank ends in scuffle, man's arrest: Homeowner charged after tackling teen he says trespassed at his home
Jul 21, 2010 10:08 AM |
BLOG
,
REGN
More News on REGN..
Press Releases
Critical Alerts For NVIDIA, Ingersoll Rand, Sotheby's, Nuance Communications, and Regeneron Pharmaceuticals Released By InvestorsObserver
May 10, 2012 09:31 AM |
BID
,
IR
,
NUAN
,
NVDA
,
REGN
Regeneron Announces Presentation at the Bank of America Merrill Lynch 2012 Healthcare Conference
May 10, 2012 09:30 AM |
REGN
Regeneron Announces Participation in J. P. Morgan Biotech: CEO/CFO Conference Call Series
May 09, 2012 09:30 AM |
REGN
More Press Releases on REGN..
SEC Filings
Form 4 REGENERON PHARMACEUTICAL For: May 21 Filed by: GOLDBERG MURRAY A (10K)
May 22, 2012 09:44 AM
Form 4 REGENERON PHARMACEUTICAL For: May 18 Filed by: SHOOTER ERIC M (10K)
May 21, 2012 03:41 PM
Form 4 REGENERON PHARMACEUTICAL For: May 02 Filed by: GOLDBERG MURRAY A (10K)
May 04, 2012 11:18 AM
More SEC Filings on REGN..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
REGN
Compare to S&P
YTD
135.05 %
117.75 %
4 Weeks
7.56 %
8.55 %
12 Weeks
13.64 %
12.16 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
129.63 %
EPS Growth in Last Year:
132.65 %
Sales Growth in Last Quarter:
88.48 %
Sales Growth in Last Quarter:
106.58 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##